[25-014297] nhlbi prat irta fellow requires genscript PO for gene synthesis, sub cloning, and plasmid prep in order to continue work looking into how rfah evolved including in vitro and in situ…
Ended Purchase Order Awarded Last action
- Contract number
- 75N92025P00334
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,999
Award facts
- Contract value 100% obligated
- $24,999.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, was made by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). The contract, valued at $24,999.00, is for gene synthesis, sub-cloning, and plasmid preparation services to support NHLBI's PRAT IRTA Fellowship program, which is investigating the evolution of the protein RFAH. The contract is a firm-fixed price purchase order and does not have a set-aside designation. Genscript has a strong track record of providing specialized molecular biology services to various federal agencies, including the NIH, Centers for Disease Control and Prevention (CDC), and United States Department of Agriculture (USDA), particularly in support of infectious disease research and pandemic response efforts.
Description
[25-014297] nhlbi prat irta fellow requires genscript PO for gene synthesis, sub cloning, and plasmid prep in order to continue work looking into how rfah evolved including in vitro and in situ experiments
Quick answers
Who was awarded contract 75N92025P00334?
75N92025P00334 was awarded to Genscript USA Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 25, 2025.
How much is contract 75N92025P00334 worth?
The government has obligated $24,999 on 75N92025P00334.
Was contract 75N92025P00334 competed?
The extent of competition for 75N92025P00334 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award